AARTI DRUGS LTD. - 524348 - Clarification On Announcement Dated Sept 20, 2024 .On USFDA Inspection At API Manufacturing Facility Of The Company

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Mid-range Performer

491.1500 9.65 (2.00%)

NSE Aug 06, 2025 15:56 PM

57.42% Gain from 52W Low

Volume: 265.5K

Aarti Drugs Ltd.

25 Sep 2024

491.15

2.00%

Company Update

AARTI DRUGS LTD. - 524348 - Clarification On Announcement Dated Sept 20, 2024 .On USFDA Inspection …

BSE India

Clarification on announcement dated Sept 20, 2024 on USFDA inspection at API manufacturing facility of the Company

More from Aarti Drugs Ltd.

Recommended

Market closes lower, Lupin's Q1 net profit surges 52.1% YoY to Rs 1,219 crore

Trendlyne Marketwatch | 06 Aug 2025, 03:56PM

Five stocks to buy from analysts this week - August 6, 2025

The Baseline | 06 Aug 2025, 10:55AM

Earnings Call Transcript - Q1FY21 for Aarti Drugs